Metraipolis › archive › dc_e2e475bbe431

Chromatin accessibility derived from cfDNA serves as a novel classification biomarker of glioma — Europe PMC PMID:41473442

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41473442
DOI
10.3389/fonc.2025.1688625
License (as archived)
solo-consultazione
Archived
2026-11-07T15:39:08.959Z
SHA-256 of the archived text
a0c27a8ac57357134549300df36ad9049da6938d8e0e95c555a3781e2240851c
Stable URL of this page
https://metraipolis.com/documento/dc_e2e475bbe431

How to cite

Chromatin accessibility derived from cfDNA serves as a novel classification biomarker of glioma — Europe PMC PMID:41473442 — Europe PMC (en), https://europepmc.org/article/MED/41473442 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2e475bbe431 (Metraipolis archive dc_e2e475bbe431, sha256 a0c27a8ac57357134549300df36ad9049da6938d8e0e95c555a3781e2240851c)
BibTeX
@misc{dce2e475bbe431,
  title = {Chromatin accessibility derived from cfDNA serves as a novel classification biomarker of glioma — Europe PMC PMID:41473442},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41473442},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2e475bbe431; sha256 a0c27a8ac57357134549300df36ad9049da6938d8e0e95c555a3781e2240851c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41473442. Agents can read the archived copy with the MCP tool read_document.